Awards and Recognition

News

 

2021

May | MCI Onehealth Announces Investment in Ariel Precision Medicine

March | Better Healthcare Through Advanced Technologies, Teletracking, Virtual Discussion Panel

August | Ariel appoints Dr. David Whitcomb, M.D., Ph.D. to Chief Scientific Officer | Data Magazine selects Ariel as a top 100 biotechnology company

September 16-17 | Jessica Gibson, CEO & Co-Founder, will be a key speaker at the RESI AI 2-Day Conference. Register now!

2020

Mission Cure Holdings, Path BioAnalytics and Ariel Precision Medicine, Launch Unique Research Alliance to Advance Treatments for Pancreatitis

Publications

2020

Moehle, C, Gibson, J. Augmenting Healthcare with Human-Centered Technologies. Journal of Commercial Biotechnology. 2020, Dec; https://doi.org/10.5912/jcb953.

Blobner, BM, et. al. Gene Expression Profiling of the Pancreas in Patients Undergoing Total Pancreatectomy With Islet Auto transplant Suggests Unique Features of Alcoholic, Idiopathic, and Hereditary Pancreatitis. Pancreas. 2020 Sep;49(8):1037-1043. doi: 10.1097/MPA.0000000000001607. PMID: 32769850*

Shelton, CA, Whitcomb, DC. Precision medicine for pancreatic diseases. Curr Opin Gastroenterol. 2020 Sep;36(5):428-436. doi: 10.1097/MOG.0000000000000665. PMID: 32740003*

Ellison, MA, et al. Complex Genetics in Pancreatitis: Insights Gained From a New Candidate Locus Panel. Pancreas. 2020 Aug;49(7):983-998. doi: 10.1097/MPA.0000000000001612. PMID: 32658084

Shelton, CA, et al. Impact of hereditary pancreatitis on patients and their families. J Genet Couns. 2020 Dec;29(6):971-982. doi: 10.1002/jgc4.1221. Epub 2020 Feb 5. PMID: 32026589*

Shelton, CA, et al. Pancreatitis Overview. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021.2014 Mar 13 [updated 2020 Jul 2]. PMID: 24624459*

Dunbar, E, et al. Constant-severe pain in chronic pancreatitis is associated with genetic loci for major depression in the NAPS2 cohort. J Gastroenterol. 2020 Oct;55(10):1000-1009. doi: 10.1007/s00535-020-01703-w. Epub 2020 Jul 17. PMID: 32681239*

2018


Zhan, W, et al. Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts. Pancreas. 2018 Sep;47(8):924-936. doi: 10.1097/MPA.0000000000001136. PMID: 30113427*

2015

Shelton, CA, et al. Genetics and Genetic Testing in Pancreatic Cancer. Gastroenterology. 2015 Oct;149(5):1252-1264.e4. doi: 10.1053/j.gastro.2015.07.057. Epub 2015 Aug 6. PMID: 26255042*

2014

Shelton, CA, et al. Genetics and treatment options for recurrent acute and chronic pancreatitis. Curr Treat Options Gastroenterol. 2014 Sep;12(3):359-71. doi: 10.1007/s11938-014-0022-y. PMID: 24954874*

LaRusch J, Jung J, General IJ, et al. Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis [published correction appears in PLoS Genet. 2014 Oct;10(10):e1004778]. PLoS Genet. 2014;10(7):e1004376. Published 2014 Jul 17. doi:10.1371/journal.pgen1004376. PMID: 25033378*

*Not published in affiliation with Ariel Precision Medicine.


LEARN MORE

QUICK LINKS

CONTACT US

(844) 692-7435 info@arielmedicine.com
5750 Centre Avenue Suite 270 Pittsburgh, PA 15206

FOLLOW US

Facebook Instagram Linkedin Twitter Youtube

© 2024 ARIEL Precision Medicine, Inc. All rights reserved. TERMS | PRIVACY